Biora Therapeutics

IN THE PRESS

Press Releases

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

October 29, 2024

·

6 min read

Press Releases

Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

October 28, 2024

·

5 min read

Press Releases

Biora Therapeutics Announces Funding Agreement with Existing Investors

October 15, 2024

·

4 min read

News

Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024

October 14, 2024

·

8 min read

Press Releases

Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

October 14, 2024

·

4 min read

Press Releases

Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

October 7, 2024

·

3 min read

Press Releases

Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024

September 30, 2024

·

3 min read

Press Releases

Biora Therapeutics Achieves ISO 13485 Certification

September 9, 2024

·

4 min read

Press Releases

Biora Therapeutics Announces Positive Nasdaq Listing Decision

August 28, 2024

·

3 min read

Press Releases

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

August 26, 2024

·

3 min read

JOBS